Skip to main content
SpringerLink
Log in

Effects of betaxolol and flunarizine on visual fields and intraocular pressure in patients with migraine

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Fifty-one patients with migraine were divided into four groups to investigate the effects of topical betaxolol and systemic calcium channel blocker flunarizine on visual fields (VF) and intraocular pressure (IOP). The first group (Group 0) was followed with no medications, topical betaxolol (bid) was precribed to the second group (Group B), oral flunarizine (10 mg daily) was prescribed to the third group (Group F), and the last group (Group BF) was assigned for combined betaxolol and flunarizine treatment. After a mean follow-up time of 4.2±1.2 months (3–6 months), IOP measurements and VF tests were repeated. Group B and Group BF were found to be statistically different from the other groups in terms of IOP reduction and VF improvement according to mean deviation and corrected pattern standard deviation indices in the second examinations. On the other hand, Group F and Group BF differed from the other two groups considering the improvement in migrainous complaints. VF findings which are probably influenced by perfusion problems due to vasospastic mechanisms in migraineurs, improved following topical betaxolol treatment. However, systemic use of flunarizine – a calcium channel blocker – did not seem to be effective on visual fields although it had beneficial effects on migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gasser P. Ocular vasospasm: A risk factor in the pathogenesis of low-tension glaucoma. Int Ophthalmol 1989; 13: 281–5.

    Google Scholar 

  2. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol 1998; 82: 862–70.

    Google Scholar 

  3. Guthauser U, Flammer J, Mahler F. The relationship between digital and ocular vasospasm. Graefe's Arch Clin Exp Ophthalmol 1988; 226: 224–6.

    Google Scholar 

  4. Gasser P, Flammer J, Guthauser U, Mahler F. Do vasospasms provoke ocular diseases? Angiology 1990; 41: 213–20.

    Google Scholar 

  5. Gasser P, Flammer J. Influence of vasospasm on visual function. Doc Ophthalmol 1987; 66: 3–18.

    Google Scholar 

  6. Wang JJ, Mitchell P, Smith W. Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study. Ophthalmology 1997; 104: 1714–9.

    Google Scholar 

  7. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 1985; 26: 1105–8.

    Google Scholar 

  8. Lewis RA, Vijayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology 1989; 96: 321–6.

    Google Scholar 

  9. Campbell JK Caselli RJ. Headache and other craniofacial pain. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice, vol. 2. Stoneham: Butterworth-Heinemann, 1989; 2: 1520–31.

    Google Scholar 

  10. Netland PA, Chanturued N, Dreyer EB. Calcium channel blockers in the management of low tension and OAG. Am J Ophthalmol 1993; 115: 608–13.

    Google Scholar 

  11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7): 1–96.

    Google Scholar 

  12. Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs 1998; 56: 811–24.

    Google Scholar 

  13. Drance SM, Douglas GR, Wijsman K, Schulzer M, Birttan RJ. Response of blood flow to warm and cold in normal and lowtension glaucoma patients. Am J Ophthalmol 1988; 105: 35–9.

    Google Scholar 

  14. Bono G, Manzoni GC, Martucci N, Baldrati A, Farina S, Cassabgi F, De Carolis P, Nappi G. Flunarizine in common migraine: Italian cooperative trial. II. Long-term follow-up. Cephalalgia 1985; 5 (Suppl 2): 155–8.

    Google Scholar 

  15. Schumer RA, Podos SM. The nerve of glaucoma. Arch Ophthalmol 1994; 112: 37–44.

    Google Scholar 

  16. Caprioli J. Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmol Scand 1997; 75: 364–7.

    Google Scholar 

  17. Netland PA, Cynthia LG, Feke GT, Hart LJ. Color Doppler ultrasound analysis of ocular ciculation after topical calcium channel blocker. Am J Ophthalmol 1995; 119: 694–700.

    Google Scholar 

  18. Kitazawa Y, Shiari H, Go FS. The effect of calcium antagonist on visual field low in tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989; 227: 408–12.

    Google Scholar 

  19. Harris A, Evans DW, Contor LB, Martin B. Hemodynamic and visual function effects of oral nifedipine in patients with normal tension glaucoma. Am J Ophthalmol 1997; 124: 296–302.

    Google Scholar 

  20. Yamamato T, Niva Y, Kavakami H, Kitazawa Y. The effect of nilvadipine, a calcium channel blocker, on the hemodynamics of retrobulber vessls in normal tension glaucoma. J Glaucoma 1998; 7: 301–5.

    Google Scholar 

  21. Gaspar AZ, Gasser P, Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 1995; 209: 11–3

    Google Scholar 

  22. Petreus JP, Leysen JE, Janssen PAJ. Calcium and sodium channels involved in neuronal cell death protection by flunarizine. Life Science 1991; 48: 1881–93.

    Google Scholar 

  23. Urenjak J, Obrenovitch O. Neuroprotective drugs presumbly acting on sodium channels. J Pharmacol Rev 1996; 21: 47–50.

    Google Scholar 

  24. Schmidt R, Oestreich W. Flunarizine in migraine prophylaxis: The clinical experience. J Cardiovasc Pharmacol 1991; 18: 21–6.

    Google Scholar 

  25. Ryck MD, Reempty JV, Borgers M. Photoreceptor stroke model flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 1989; 20: 1383–90.

    Google Scholar 

  26. Alps BJ, Hass WK, Wilson AD. Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine agonist ischaemic injury in the hipocampus of the mongolian gerbil. Br J Ophthalmol 1988; 93: 877–83.

    Google Scholar 

  27. Peters T, Wilffert B, Van Houtte PM, Van Zwiete PA. Calcium channel in the brain as targets for the calcium channel modulators used in the treatment of neurological disorders. J Cardiovasc Pharmacol 1991; 18 (Suppl): S1–5.

    Google Scholar 

  28. Lam TT, Fu J, Mrynewycz M, Tso MO. The effect of carboxylic acid an endonuclease inhibitor on ischemia/reperfusion damage in rat retina. J Ocul Pharmacol Ther 1995; 11: 253–9.

    Google Scholar 

  29. Cellini M, Possati GL, Caramazza N, Profazio U, Caramazza R. The use of flunarizine in the management of low tension glaucoma. A color Doppler study. Acta Ophthalmol Scand 1997; 224: 57–65.

    Google Scholar 

  30. Collignon-Brunch J. Long term effect of topical beta blockers on intraocular pressure and visual field sensitivity in ocular hypertension and COAG. Surv Ophthalmol 1994; 38: 149–55.

    Google Scholar 

  31. Turaçli ME, Özden RG, Gürses MA. The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucoma. Eur J Ophthalmol 1998; 8: 62–6.

    Google Scholar 

  32. Yu D, Su E, Cringle S, Alder V, Yu P, DeSantis L. Systemic and ocular vascular roles of the antiglaucoma agents β-adrenergic antagonists and Ca entry blockers. Surv Ophthalmol 1999; 43 (Suppl): S214–22.

    Google Scholar 

  33. Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JP, Nash MS. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 1999; 43 (Suppl): S102–28.

    Google Scholar 

  34. Wöber C, Wöber-Bingöl C, Koch G, Wessely P Long-term results of migraine prophylaxis with flunarizine and betablockers. Cephalalgia 1991; 11: 251–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1st Eye Clinic, Ankara Numune Training and Research Hospital, Ankara, Turkey

    Alper Yarangümeli, Özlem Gürbüz Köz & Gülcan Kural

  2. Neurology Clinic, Ankara Numune Training and Research Hospital, Ankara, Turkey

    Selçuk Çomoglu

  3. Division of Biostatistics, Medical Faculty of Ankara University, Ankara, Turkey

    Atilla Halil Elhan

Authors
  1. Alper Yarangümeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Selçuk Çomoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Özlem Gürbüz Köz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atilla Halil Elhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gülcan Kural
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yarangümeli, A., Çomoglu, S., Gürbüz Köz, Ö. et al. Effects of betaxolol and flunarizine on visual fields and intraocular pressure in patients with migraine. Doc Ophthalmol 106, 265–270 (2003). https://doi.org/10.1023/A:1022925432197

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022925432197

Search

Navigation